Pirfenidone	NNP	Pirfenidone O TermTag
for	IN	for O TermTag
the	DT	the O TermTag
treatment	NN	treatment O TermTag
of	IN	of O TermTag
idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

Idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
is	VBZ	be O TermTag
an	DT	a O TermTag
under-recognised	JJ	under-recognised O TermTag
,	,	, , NUPOS
rare	JJ	rare O TermTag
,	,	, , NUPOS
progressive	JJ	progressive O TermTag
disease	NN	disease O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
lungs	NNS	lung O TermTag
with	IN	with O TermTag
unknown	JJ	unknown O TermTag
aetiology	NN	aetiology O TermTag
and	CC	and O TermTag
high	JJ	high O TermTag
mortality	NN	mortality O TermTag
.	.	. . NUPOS

The	DT	the O TermTag
currently	RB	current O TermTag
advocated	VBN	advocate O TermTag
pathogenic	JJ	pathogenic O TermTag
mechanism	NN	mechanism O TermTag
is	VBZ	be O TermTag
represented	VBN	represent O TermTag
by	IN	by O TermTag
progressive	JJ	progressive O TermTag
multifocal	JJ	multifocal O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

It	PRP	it O TermTag
is	VBZ	be O TermTag
diagnosed	VBN	diagnose O TermTag
based	VBN	base O TermTag
on	IN	on O TermTag
clinical	JJ	clinical O TermTag
,	,	, , NUPOS
radiographic	JJ	radiographic O TermTag
,	,	, , NUPOS
physiological	JJ	physiological O TermTag
and	CC	and O TermTag
histopathological	JJ	histopathological O TermTag
criteria	NNS	criterion O TermTag
.	.	. . NUPOS

Existing	VBG	exist O TermTag
therapeutic	JJ	therapeutic O TermTag
guidelines	NNS	guideline O TermTag
recommend	VBP	recommend O TermTag
anti-inflammatory	JJ	anti-inflammatory O TermTag
and	CC	and O TermTag
immunosuppressive	JJ	immunosuppressive O TermTag
combinations	NNS	combination O TermTag
,	,	, , NUPOS
despite	IN	despite O TermTag
proven	JJ	proven O TermTag
limited	JJ	limited O TermTag
efficacy	NN	efficacy O TermTag
.	.	. . NUPOS

There	EX	there O TermTag
is	VBZ	be O TermTag
no	DT	no O TermTag
therapy	NN	therapy O TermTag
approved	VBD	approve O TermTag
specifically	RB	specific O TermTag
for	IN	for O TermTag
IPF	NN	IPF O TermTag
,	,	, , NUPOS
but	CC	but O TermTag
several	JJ	several O TermTag
antifibrotic	JJ	antifibrotic O TermTag
agents	NNS	agent O TermTag
are	VBP	be O TermTag
currently	RB	current O TermTag
under	IN	under O TermTag
development	NN	development O TermTag
for	IN	for O TermTag
this	DT	this O TermTag
indication	NN	indication O TermTag
.	.	. . NUPOS

Pirfenidone	NNP	Pirfenidone O TermTag
is	VBZ	be O TermTag
an	DT	a O TermTag
antifibrotic	JJ	antifibrotic O TermTag
agent	NN	agent O TermTag
potentially	RB	potential O TermTag
effective	JJ	effective O TermTag
for	IN	for O TermTag
IPF	NN	IPF O TermTag
therapy	NN	therapy O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
preclinical	JJ	preclinical O TermTag
and	CC	and O TermTag
available	JJ	available O TermTag
clinical	JJ	clinical O TermTag
data	NNS	datum O TermTag
support	VBP	support O TermTag
its	PRP$	its O TermTag
use	NN	use O TermTag
in	IN	in O TermTag
IPF	NN	IPF O TermTag
.	.	. . NUPOS

Future	JJ	future O TermTag
clinical	JJ	clinical O TermTag
studies	NNS	study O TermTag
are	VBP	be O TermTag
expected	VBN	expect O TermTag
to	TO	to O TermTag
provide	VB	provide O TermTag
more	JJR	many O TermTag
consistent	JJ	consistent O TermTag
information	NN	information O TermTag
on	IN	on O TermTag
survival	NN	survival O TermTag
benefit	NN	benefit O TermTag
,	,	, , NUPOS
lung	NN	lung O TermTag
function	NN	function O TermTag
and	CC	and O TermTag
health-related	JJ	health-related O TermTag
quality	NN	quality O TermTag
of	IN	of O TermTag
life	NN	life O TermTag
.	.	. . NUPOS

